Best healthcare AI UX design agencies in 2026

A healthcare AI UX design agency designs the interfaces that clinicians use to read an AI recommendation, assess how much to trust it, and act on it, all within healthcare’s regulatory and workflow constraints. The work demands fluency in two fields that rarely share a roof, clinical interface design and AI interaction design, and the quickest way to tell who genuinely has both is to ask which AI product they have worked on inside a real clinical setting and what that interface does when the model is uncertain.

Search “healthcare UX agency,” and you find dozens of firms fluent in patient journey mapping, EHR interface design, and accessibility compliance. Search “AI UX agency,” and you find a different skill set entirely: prompt interface design, automation, model-output visualization, and human-AI interaction patterns. Ask either group whether they have participated in bringing an AI medical device through FDA clearance, and the room gets much quieter. Agencies that do both well are still rare.

Healthcare AI is no longer a niche. The FDA has authorized more than 1,400 AI-enabled medical devices to date, and 2025 was the biggest year on record, with close to 300 clearances. Behind almost every one of those products is an interface a clinician has to trust: a dashboard a care coordinator relies on, an alert a physician acts on, a risk score that changes a treatment decision. Those interfaces are frequently the last checkpoint between a wrong output and the patient who receives it.

What makes this category genuinely difficult is that it inherits the operational complexity of healthcare and the ambiguity of AI at the same time. The danger in a clinical AI product is rarely that the model is wrong. The danger is that a wrong output looks trustworthy, and the interface is what decides whether it does.

So the screen cannot just present a recommendation clearly. It has to help a clinician judge whether to believe that recommendation, by showing what evidence supports it, how confident the model is, what data the model may be missing, and where the model tends to fail. At that point the interface stops being a presentation layer and becomes part of the clinical reasoning itself.

What healthcare AI UX design actually requires

Designing the interface for a healthcare AI product is its own discipline, not a variation on standard UX work. The constraints are regulatory, clinical, technical, and ethical at once, and they do not exist in this combination in consumer or enterprise AI design. The agencies that handle it have usually learned each layer the hard way, on shipped products instead of from a framework.

Regulatory fluency is the requirement that separates the strongest healthcare UX design teams from the rest. The FDA’s Software as a Medical Device framework governs software that performs a medical function, and AI products sit at its most demanding end. In January 2025 the FDA published draft guidance on AI-enabled device software functions covering lifecycle management and marketing submissions, and almost all of it touches the interface. If an AI highlights an image or produces a risk score, the agency expects evidence that clinicians were trained to understand it.

HIPAA compliance lives in the data architecture of the interface layer, not just the back end. Where protected health information appears, how it is masked in shared views, what happens to patient data inside AI feedback loops, and how consent is communicated in real-time are all UX decisions with legal exposure. Agencies that have only worked in consumer AI or non-regulated enterprise software routinely underestimate how large that surface area is, and how painstaking and costly it can be if not managed correctly.

Explainability is a design surface, not a feature. The FDA’s transparency guidance for machine-learning-enabled devices expects that clinicians and patients receive appropriate information about the logic behind a recommendation, its risks, and its limits. Translating that expectation into an actual interface is specialized work, because it requires both clinical context and a real understanding of how people reason about probability under pressure.

Clinical workflow integration is where most healthcare AI products stumble, and usually not because the model is wrong. They stumble because the interface does not fit how clinicians actually work: how a nurse documents across a shift, how an attending reviews alerts under stress, how one screen has to serve several patients at once. That knowledge comes from watching real users in real settings, not from a requirements document.

Human factors documentation is the last non-negotiable. FDA submissions for AI/ML devices require evidence that representative users can operate the device safely and effectively, produced through structured research with defined protocols, documented error analysis, and findings that feed the regulatory record. A standard usability test report will not satisfy this requirement. An agency that cannot produce this level of analysis and findings cannot design a regulated AI product.

Why most healthcare UX agencies cannot do AI well, and the reverse

The healthcare UX market and the AI UX market developed in parallel for most of a decade, with very little overlap, and the firms that dominate each one built fundamentally different design instincts. Healthcare UX grew out of operational complexity, organized around compliance, workflow structure, and administrative legibility. AI UX grew out of probabilistic interaction, optimized for adaptive systems, conversation, and automation. Expecting a specialist in one to be fluent in the other usually ends in a product that disappoints.

Established healthcare UX agencies built their reputations making complex clinical data legible: EHR usability, patient portals, care coordination dashboards. That work is genuinely hard, and the best of them have real depth in clinical workflow and accessibility. But it trained them to treat the interface as a structured display of known data, such as lab results, medication orders, or protocols. The interface shows the information; the clinician decides.

AI breaks that model at the root because AI output is probabilistic and can be wrong in ways invisible to the clinician reading the screen. Which, in all honesty the top of the the healthcare AI heap, when it comes to problems in this space. However, the failure pattern is specific and easy to spot once you know it. A healthcare team applying its fixed-data instincts to AI renders a confidence score as a static number beside the recommendation, the same way it would show a lab value.

Clinicians read that number once, decide the model seems confident, and stop checking. A signal meant to provoke scrutiny, designed as a data field, does the opposite. The interface looks correct in a demo and then erodes clinician trust within the first few weeks of real use, which is the point where most of these products quietly stall.

AI-first agencies make the mirror-image mistake, and three things tend to be missing. Regulatory knowledge is the obvious one: FDA human factors expectations, HIPAA constraints on the interface, SaMD classification. Clinical context is subtler and more damaging. A team that has spent three years on consumer copilots ships a clean single-answer interface optimised for one user exploring one question, then deploys it into the workflow of a care coordinator triaging nine patients at once. That coordinator needs the recommendation, the evidence behind it, and the override visible in the same glance, not one tap deeper.

The error tolerance, the trust threshold, and the cost of a miscalibrated confidence signal are all far higher than that team is used to. The third gap surfaces only at deployment: most AI interface design teams have never shipped anything that runs inside Epic or Cerner, and the technical constraints, workflow hooks, and adoption realities of those systems break designs that tested cleanly in isolation.

This is why the set of agencies genuinely capable of healthcare AI work stays small. The strongest can point to specific clinical AI engagements and explain exactly how they handled model uncertainty, explainability, and clinician override workflows. Bolting AI services onto a healthcare practice, or adding a healthcare page to an AI practice, does not produce that.

What to look for in a healthcare AI UX design agency

The best healthcare AI UX design agencies build systems that make AI reasoning visible and verifiable inside environments where clinicians have to weigh risk and uncertainty under time and cognitive pressure, while staying compliant with the sector’s regulations. To find the right partner, look past the pitch deck for evidence in a few specific areas: shipped AI products in real clinical settings, demonstrated command of healthcare regulation, direct knowledge of clinical workflow, and a clear approach to explainability and human-in-the-loop review.

Portfolio evidence comes first, and it has to be specific. Not speculative case studies, not AI features added to a wellness app, not concept prototypes. Ask directly: which AI product did you ship, in which clinical setting does it run, and what does the interface do when the model is uncertain? The answer to that last question separates teams who have wrestled with healthcare AI interaction from teams who have designed around it.

Regulatory familiarity matters more than most AI agencies expect. Healthcare introduces requirements general AI firms rarely meet: HIPAA constraints, auditability, traceability, documentation standards, and FDA-adjacent considerations for clinical systems. Ask how the team approaches HIPAA-constrained interface design, or whether they have produced FDA human factors submissions. An agency with real experience names specific interface decisions and explains why they mattered. Others stop at general data-privacy principles. In healthcare, recommendation traceability is part of operational accountability, and confidence communication can materially change how a clinician relies on an AI output.

Clinical workflow understanding has to come from direct observation. Find out how the agency runs clinical research. The answer should include shadowing, contextual inquiry in actual care settings, and iterative testing with nurses, physicians, or other staff. Agencies that lean on sponsor-side interviews and secondary research produce designs that do not survive contact with a real ward.

Buyers in federal or state health agencies face requirements most firms never encounter, including Section 508 accessibility, ATO processes, and government contract vehicles. For that segment, an agency’s government health track record functions as a baseline qualification, and most agencies on any healthcare list simply do not have one.

How an agency handles transparency and explainability is arguably the single biggest differentiator in healthcare AI UX today. Most AI products are optimized to generate an answer. Healthcare AI has to support the evaluation of one. A clinician needs to see why a recommendation exists, what evidence backs it, and how confident the system is, and none of that can sit behind a secondary workflow. Clinicians are not browsing the system the way a consumer explores a chatbot; they are making judgment calls under pressure across several patients at once. The moment explainability becomes a “view sources” link or an accordion detached from the recommendation, the interface has failed at its clinical job.

Finally, look for genuine human-in-the-loop expertise. Most successful healthcare AI systems are collaborative, not autonomous: clinicians validate outputs, override recommendations, escalate edge cases, and audit decisions. The override path is often the feature clinicians test first and trust least when it is buried, and how an agency designs that path tells you quickly whether it has watched clinicians use AI under pressure or only read about it. An agency that pushes for maximum automation and treats override and validation as edge cases has not designed for a real clinical environment.

Best healthcare AI UX design agencies in 2026

No agency on this list is best for every healthcare AI project. Each is strongest in a different segment, and which firm to shortlist depends on the kind of work: federal procurement, FDA-regulated products, enterprise platforms, patient-facing tools, or earlier-stage discovery and category development. The entries below describe what each agency is genuinely good at, not a single overall ranking.

1. Fuselab Creative

McLean, VA. Hourly rate: $100 to $149. Minimum project: $25,000. Clutch rating: 5.0 Strongest for: Clinician-facing AI systems, data-dense intelligence platforms, and complex healthcare workflows.

Fuselab Creative sits unusually close to the center of this category. Its portfolio combines operational healthcare complexity with AI systems work. DHCS brought state-Medicaid scale with the accessibility and workflow constraints that come with one of the largest health programs in the country. ClyHealth added clinical AI care coordination, where the interface has to make supporting evidence and model confidence legible in the same glance so a coordinator can act without leaving the screen. NIH added federal research credentialing. A clinical AI startup, a state health agency, and a federal research institution in a single active portfolio is uncommon. For regulated healthcare AI buyers, particularly those operating in or near government health systems, it is one of the most complete profiles on this list.

2. Guidea (now part of Invene)

Austin, TX. Hourly rate: $150 to $199. Minimum project: $50,000. Clutch rating: 4.8 Strongest for: FDA-cleared digital therapeutics, SaMD, clinical AI decision support, and biopharma digital health.

Guidea has spent more than two decades in regulated digital health and, by its own account, has contributed to over 300 live products and served a large share of the Fortune 100 in healthcare and life sciences. Its AI portfolio includes clinical decision support, population health work with ClosedLoop.ai, and digital twin design for radiology operations with Quantivly, with clients such as Amgen, AstraZeneca, Johnson & Johnson, Humana, Cigna, and Samsung Health. The team also worked on two of the earliest digital therapeutics to win FDA approval and reimbursement, a level of submission-stage involvement few agencies have. Invene acquired Guidea in May 2025 to build a full-stack regulated healthcare product capability. The combined firm is strongest for commercial digital health and biopharma, and less focused on federal or state health procurement.

3. Momentum

Wrocław, Poland. Hourly rate: $50 to $99. Minimum project: $50,000. Clutch rating: 4.8 Strongest for: Enterprise healthcare platforms, AI-enabled workflow systems, and healthcare SaaS products.

Momentum positions itself more directly around healthcare AI development than most traditional UX firms on this list. It pairs healthcare product design with software engineering, AI implementation, and compliance-focused infrastructure, giving it a fuller-stack profile than interface-only agencies. Its open-source healthcare tooling, including HealthStack, FHIRboard, and AI documentation processing, suggests a company thinking past surface UX and into healthcare AI operationalization at scale. Named clients include VillaMedica and zdroVeno, alongside others under NDA. Compared with more strategy-led firms, Momentum is noticeably more engineering- and infrastructure-oriented, which makes it most relevant for organizations building AI-heavy operational platforms and scalable clinical infrastructure.

4. Koru UX Design

Pune, India. Hourly rate: $50 to $99. Minimum project: $50,000. Clutch rating: 4.7 Strongest for: Patient-centered healthcare AI experiences and empathetic healthcare UX.

Koru approaches healthcare AI from a strongly human-centered and behavioral angle, with a focus on empathy, emotional usability, and patient trust, particularly in AI-assisted experiences where communication clarity matters as much as function. The agency reports more than 1,500 healthcare UX projects spanning EHRs, AI and LLM features, pharmacy management, patient portals, dashboards, and analytics. Compared with the enterprise-systems firms here, Koru is more patient-experience-focused and less infrastructure-heavy, which makes it a strong fit for patient-facing AI products and digital health platforms. Its India-based operating model may be a limitation for organizations that need a US-based team or close involvement in regulated enterprise procurement and governance.

5. Cieden

Ivano-Frankivsk, Ukraine, and Toronto, Canada. Hourly rate: $50 to $99. Minimum project: $10,000. Clutch rating: 4.8 Strongest for: AI-enabled healthcare dashboards, analytics systems, and data-heavy healthcare platforms.

Cieden has built its reputation on complex B2B product environments where dense information and operational workflow shape the interface. Its healthcare AI strength is less about patient engagement and more about making complicated systems usable without oversimplifying them, which shows in analytics-heavy workflows and operational dashboards where information hierarchy and decision visibility carry the weight. That translates well into care-operations and internal healthcare platforms. The distributed Ukraine-and-Canada model offers lower pricing, but organizations in heavily regulated US environments may find limits in security governance and cross-team coordination.

6. IDEO

San Francisco, CA, with studios across the US, Europe, and Asia. Pricing not listed on Clutch. Strongest for: Strategic healthcare product design, digital therapeutics, and ventures defining new categories of care.

IDEO occupies a different position from the execution-focused specialists on this list. Its healthcare practice runs as a multi-million-dollar portfolio with dedicated leadership across San Francisco, Chicago, and London, including a Harvard-trained emergency medicine physician as Executive Portfolio Director of Health. The portfolio includes Omada Health, which grew from an IDEO research project into a billion-dollar chronic disease company, Teal Health’s at-home cervical cancer screening, UCSF’s Prime mental health app for schizophrenia, and digital therapeutics work for Massachusetts Department of Mental Health and Together Senior Health. IDEO has published directly on healthcare AI, including a piece adapted from a talk delivered at the American Medical Informatics Association Clinical Informatics conference. The fit is strongest for organizations defining a new product category or transforming care delivery at scale, rather than for buyers shipping a specific clinical interface to FDA submission.

How we evaluated these agencies

This list was built around a single filter: agencies that demonstrate both healthcare domain depth and a shipped AI product. Neither credential alone qualified an agency for inclusion.

The evaluation drew on four inputs. Portfolio evidence carried the most weight, which meant shipped products in clinical or regulated health environments, not speculative case studies or AI features bolted onto non-regulated products. Regulatory process depth was the second filter and the one most agencies failed on: direct involvement in FDA human factors studies, HIPAA-constrained interface design, or government health procurement, plus the ability to describe that work in specifics rather than generalities. AI UX maturity covered comfort designing around explainability, confidence scoring, uncertainty communication, and human-in-the-loop review. Operational model was the last filter, covering location, team structure, pricing, and procurement fit, and it was the one that most often decided which credible agency was actually engageable.

Clutch ratings, public portfolio documentation, and agency website content were used to verify claims. Agencies that could not show shipped healthcare AI work were excluded regardless of general reputation. For the broader category that sits one step out from AI, our guide to the best healthcare UX design agencies in 2026 covers firms strong in clinical UX without a deep AI specialism.

This list is the healthcare-specific cut of a wider field. If your product is an AI interface outside healthcare, our broader roundup of the best AI UX design agencies in 2026 ranks firms across enterprise, fintech, and consumer AI without the clinical and regulatory filter applied here.

Healthcare AI UX design agency comparison

What drives the cost of a healthcare AI UX project

Healthcare AI UX costs more than general AI UX work for reasons that have little to do with the screens and everything to do with what has to be proven about them. Oh, and by the way, it costs more because this stuff is really hard to do right. A consumer AI interface is done when it tests flawlessly. A clinical AI interface is deemed complete when there is documented evidence that representative users can operate it safely and in a timely manner, and that accounts for most of the cost.

Three things move the number, and the biggest is the human factors validation study: structured protocols, recruited clinical participants, recorded error analysis, and a report written to survive an FDA reviewer rather than an internal sign-off. Traceability and documentation come next because, in a regulated product, every recommendation, confidence signal, and override must be auditable, and designing for auditability is more work than designing for a clean demo. And not to be dramatic, but we are talking about a person’s health and well-being. Last is the research method, where real clinical shadowing and contextual inquiry cost more than remote interviews, and where less specialized agencies most often cut corners.

This is why the ranges on this page spread so widely. A smaller, well-scoped clinical AI engagement runs roughly $25,000 to $75,000, while an enterprise program with full submission support and multi-role workflows reaches several hundred thousand. An agency quoting consumer-AI prices for a regulated product has almost always left the documentation and validation work out of scope, and that gap reappears later as either a failed submission or a second engagement.

How to choose the right healthcare AI UX agency

The right healthcare AI UX design agency depends on three things: the kind of AI product you are building, the regulatory environment it must navigate, and the procurement vehicle your organization uses. Federal agencies, digital health startups, and enterprise health systems each shortlist different firms, usually for non-overlapping reasons.

If you are a federal or state health agency, the shortlist starts and largely ends with firms that hold government contract vehicles, have Section 508 experience, and understand ATO processes. Fuselab’s GSA Schedule contract (47QTCA22D00CV) allows direct engagement without a full competitive RFP. Every other agency on this list will mean a longer procurement path and a steeper compliance learning curve, and most will struggle with federal accessibility and authorization requirements they do not encounter in commercial work.

If you are a digital health startup or biopharma company building a regulated product, the filter is FDA process depth. Guidea is one of the most credentialed pure-design options in that category, with submission-stage involvement on early FDA-cleared digital therapeutics. For products that also need full-stack design and engineering capability under one roof, Momentum’s infrastructure-oriented model is worth a look. For earlier-stage ventures still defining the product category or care delivery model, IDEO’s strategic healthcare practice is a natural fit before execution-focused engagement begins.

If you are a health system or enterprise building internal AI tools or patient-facing platforms, prioritize demonstrated human-in-the-loop experience, where Koru is strong. For data-dense internal platforms where enterprise B2B depth matters more than regulated submission experience, Cieden’s analytics and dashboard work is worth considering.

Healthcare AI is still a narrow overlap market. Most healthcare UX agencies do not deeply understand AI systems, and most AI UX agencies do not deeply understand healthcare operations. The partnerships that work tend to be the ones where the agency’s operational background already matches the environment the product will run in.